These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 26759404)
21. A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis. Yazici Y; Erkan D; Lockshin MD Clin Exp Rheumatol; 2000; 18(6):732-4. PubMed ID: 11138337 [TBL] [Abstract][Full Text] [Related]
22. A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis. Kitamura G; Mehr N; Anderson N; Sirichotiratana M Dermatol Online J; 2009 Feb; 15(2):11. PubMed ID: 19336028 [TBL] [Abstract][Full Text] [Related]
23. Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy. Hamilton TK J Drugs Dermatol; 2008 Nov; 7(11):1089-93. PubMed ID: 19110745 [TBL] [Abstract][Full Text] [Related]
28. First fatal case of systemic suppurative/necrotizing granulomatous disease following etanercept therapy for psoriasis. Turashvili G; Farmer P J Dermatolog Treat; 2015 Apr; 26(2):124-7. PubMed ID: 24646144 [TBL] [Abstract][Full Text] [Related]
29. [Development of mesangial immunoglobulin IgA glomerulonephritis and p-ANCA positivity in a patient with psoriatic arthritis]. Nazzaro P; Battaglia R; D'Altri C; Marangi AL; Perniola M; Rodio A; De Padova F G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067220 [TBL] [Abstract][Full Text] [Related]
30. Myositis in primary Sjögren's syndrome: data from a multicentre cohort. Colafrancesco S; Priori R; Gattamelata A; Picarelli G; Minniti A; Brancatisano F; D'Amati G; Giordano C; Cerbelli B; Maset M; Quartuccio L; Bartoloni E; Carubbi F; Cipriani P; Baldini C; Luciano N; De Vita S; Gerli R; Giacomelli R; Bombardieri S; Valesini G Clin Exp Rheumatol; 2015; 33(4):457-64. PubMed ID: 26088683 [TBL] [Abstract][Full Text] [Related]
31. Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept. Mease PJ; Kivitz AJ; Burch FX; Siegel EL; Cohen SB; Ory P; Salonen D; Rubenstein J; Sharp JT; Dunn M; Tsuji W J Rheumatol; 2006 Apr; 33(4):712-21. PubMed ID: 16463435 [TBL] [Abstract][Full Text] [Related]
32. Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens. Gniadecki R; Robertson D; Molta CT; Freundlich B; Pedersen R; Li W; Boggs R; Zbrozek AS J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1436-43. PubMed ID: 22035157 [TBL] [Abstract][Full Text] [Related]
33. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial. Gladman DD; Bombardier C; Thorne C; Haraoui B; Khraishi M; Rahman P; Bensen W; Syrotuik J; Poulin-Costello M J Rheumatol; 2011 Jul; 38(7):1355-62. PubMed ID: 21572156 [TBL] [Abstract][Full Text] [Related]
35. [Myositis in the presence of slightly elevated creatine kinase values]. van Vonderen MG; ter Maaten JC; van der Valk P; Hoorntje SJ; Gans RO Ned Tijdschr Geneeskd; 1999 May; 143(18):949-53. PubMed ID: 10368712 [TBL] [Abstract][Full Text] [Related]
37. Etanercept for the treatment of psoriasis: combination therapy with other modalities. Strober BE; Clarke S J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus. Mikhail M; Weinberg JM; Smith BL Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038 [No Abstract] [Full Text] [Related]
39. Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis. Murdaca G; Negrini S; Magnani O; Penza E; Pellecchio M; Puppo F Expert Opin Drug Saf; 2017 Oct; 16(10):1173-1179. PubMed ID: 28750567 [TBL] [Abstract][Full Text] [Related]
40. Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literature. Mourão AF; Rustin M; Isenberg D Clin Exp Rheumatol; 2010; 28(3):408-10. PubMed ID: 20576227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]